S 2683 · 118th Congress 2023–2025, ended

AMERICAN DRUGS Act

Latest action · Jul 27, 2023 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJul 27, 2023
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Accelerating Movement of Essential Rx Items to Create Access to National Drug Resources for US Government Services Act or the AMERICAN DRUGS Act

This bill generally limits coverage of generic drugs under federal health care programs to those that are manufactured domestically.

Specifically, the bill prohibits coverage of generic drugs that are manufactured in foreign countries under Medicare, Medicaid, the Children's Health Insurance Program (CHIP), TRICARE, and benefits provided by the Veterans' Administration. Coverage is permitted for foreign-made generic drugs if there are fewer than two other generic versions that are manufactured domestically or if the generic versions that are manufactured domestically are in shortage or soon to be discontinued. The Food and Drug Administration (FDA) must notify appropriate agencies about brand-name drugs that have at least two generic versions that are manufactured domestically and those that do not. 

The bill also allows the FDA to expedite the development and review of applications for generic versions of brand-name drugs that do not have at least two generic versions that are manufactured domestically.

Cosponsors 2

Members who signed on, in the order they did. All signed on Sep 5, 2023.

SeatCosponsorSigned on
R-OHJ. D. VanceSep 5, 2023
R-INMike BraunSep 5, 2023

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateHealth, Education, Labor, and Pensions Committee
Referred Jul 27, 2023

Actions 2

Everything that happened, newest first.

  1. Jul 27, 2023Introduced in Senate
  2. Jul 27, 2023Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to establish requirements for purchasing certain generic drugs from manufacturers who produce the drug domestically.
Short Title(s) as Introduced
Accelerating Movement of Essential Rx Items to Create Access to National Drug Resources for US Government Services Act
AMERICAN DRUGS Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jul 27, 2023Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.